Prudential Financial
BEAM icon

Prudential Financial’s Beam Therapeutics BEAM Stock Holding History

Prudential Financial’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Buy
+14,925
New +$414K ﹤0.01% 1971
2025
Q4 		– Sell
-11,890
Closed -$289K – 2236
2025
Q3 		$289K Buy
11,890
+45
+0.4% +$895 ﹤0.01% 2105
2025
Q2 		$245K Buy
+11,845
New +$206K ﹤0.01% 2152
2024
Q4 		– Sell
-14,089
Closed -$345K – 2316
2024
Q3 		$345K Buy
+14,089
New +$364K ﹤0.01% 2361
2022
Q2 		– Sell
-3,900
Closed -$224K – 2671
2022
Q1 		$224K Buy
3,900
+25
+0.6% +$1.64K ﹤0.01% 2488
2021
Q4 		$309K Sell
3,875
-325
-8% -$27.8K ﹤0.01% 2392
2021
Q3 		$365K Buy
4,200
+475
+13% +$47.7K ﹤0.01% 2255
2021
Q2 		$479K Buy
3,725
+420
+13% +$33.5K ﹤0.01% 2154
2021
Q1 		$265K Buy
3,305
+300
+10% +$28.5K ﹤0.01% 2315
2020
Q4 		$245K Buy
+3,005
New +$148K ﹤0.01% 2306

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Prudential Financial's BEAM Position: Q1 2026 in Review

Prudential Financial opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 14,925 shares worth $356K. The stake represents ﹤0.01% of the portfolio and ranks #1971 among its holdings. This is a return to the name: Prudential Financial previously reported a position in BEAM as recently as Q3 2025.

Prudential Financial first reported a position in BEAM in Q4 2020 and has held it in 10 quarters since. The position peaked at $479K in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Prudential Financial held 14,925 shares of Beam Therapeutics worth $356K as of Q1 2026.
  • Beam Therapeutics was a new Prudential Financial position in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1971 holding.
  • Prudential Financial first reported a position in Beam Therapeutics in Q4 2020 and has held it in 10 quarters since.
  • Prudential Financial's Beam Therapeutics position peaked at $479K in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.